Bnp Paribas Asset Management Holding S.A. Regeneron Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $41 Billion
- Q2 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 440,424 shares of REGN stock, worth $258 Million. This represents 0.56% of its overall portfolio holdings.
Number of Shares
440,424
Previous 532,214
17.25%
Holding current value
$258 Million
Previous $338 Million
31.5%
% of portfolio
0.56%
Previous 0.91%
Shares
31 transactions
Others Institutions Holding REGN
# of Institutions
1,431Shares Held
88.9MCall Options Held
1.98MPut Options Held
1.75M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.52 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.94 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.31 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.83 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.24 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $62.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...